Takeda Pharmaceutical Company(MX:TAKN)
MX$345.000.00 (0.00%)
MX:TAKN
Takeda Pharmaceutical Company earnings date
MX$345.00
At close:0.00 (0.00%)
Takeda Pharmaceutical Company (TAKN) Q2 2021 Earnings Report
0 Followers
MX:TAKN Q2 2021 EPS Results
- Actual EPS
- -MXN 0.89
- Consensus EPS
- MXN 4.33
- Beat/Miss
- Missed by -MXN 5.22
- One Year Ago EPS
- MXN 0.22
MX:TAKN Q2 2021 Revenue Results
- Actual Revenue
- MXN 142.66B
- Expected Revenue
- MXN 136.88B
- Beat/Miss
- Beat by +MXN 5.78B
- YoY Revenue Growth
- +3.25%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 10/28/2021
- Time
- Before Open
- Conference Call
- Thursday, October 28, 2021
MX:TAKN Upcoming Earnings
Takeda Pharmaceutical Company's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:TAKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 2.64- | 3.96 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 2.707.14 | -0.46 | 1636.00% (+7.60) | |
| Jul 30, 2026 | 2026 (Q1) | 3.144.18 | 4.91 | -14.77% (-0.72) | |
| May 13, 2026 | 2025 (Q4) | -1.39-0.91 | -4.24 | 78.51% (+3.33) | |
| Jan 29, 2026 | 2025 (Q3) | 2.533.96 | 0.91 | 334.69% (+3.05) | |
| Oct 30, 2025 | 2025 (Q2) | 1.30-0.46 | 3.53 | -113.16% (-4.00) | |
| Jul 29, 2025 | 2025 (Q1) | 3.164.91 | 3.77 | 30.05% (+1.13) | |
| May 08, 2025 | 2024 (Q4) | -0.52-4.24 | -0.13 | -3157.14% (-4.11) | |
| Jan 30, 2025 | 2024 (Q3) | 1.580.91 | 4.24 | -78.51% (-3.33) | |
| Oct 31, 2024 | 2024 (Q2) | 2.313.53 | -1.93 | 282.69% (+5.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
